Molecular interactions of salvinorin a at the kappa opioid receptor.

被引:0
|
作者
Kane, BE
McCurdy, CR
Ferguson, DM
机构
[1] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Mississippi, Dept Med Chem, University, MS 38677 USA
[3] Univ Mississippi, Lab Appl Drug Design & Synth, University, MS 38677 USA
[4] Univ Minnesota, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
273-MEDI
引用
收藏
页码:U57 / U57
页数:1
相关论文
共 50 条
  • [31] Molecular mechanism of biased signaling at the kappa opioid receptor
    El Daibani, Amal
    Paggi, Joseph M. M.
    Kim, Kuglae
    Laloudakis, Yianni D. D.
    Popov, Petr D.
    Bernhard, Sarah M. M.
    Krumm, Brian E. E.
    Olsen, Reid H. J.
    Diberto, Jeffrey
    Carroll, F. Ivy
    Katritch, Vsevolod
    Wuensch, Bernhard
    Dror, Ron O. O.
    Che, Tao
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Molecular mechanism of biased signaling at the kappa opioid receptor
    Amal El Daibani
    Joseph M. Paggi
    Kuglae Kim
    Yianni D. Laloudakis
    Petr Popov
    Sarah M. Bernhard
    Brian E. Krumm
    Reid H. J. Olsen
    Jeffrey Diberto
    F. Ivy Carroll
    Vsevolod Katritch
    Bernhard Wünsch
    Ron O. Dror
    Tao Che
    Nature Communications, 14
  • [33] Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation
    Paterlini, G
    Portoghese, PS
    Ferguson, DM
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) : 3254 - 3262
  • [34] Molecular interactions between CCK ligands and the CCKA receptor.
    Tsunoda, Y
    Song, I
    Taylor, LP
    Owyang, C
    GASTROENTEROLOGY, 1997, 112 (04) : A1196 - A1196
  • [35] Synthesis of salvinorin A analogues as opioid receptor probes
    Tidgewell, Kevin
    Harding, Wayne W.
    Lozama, Anthony
    Cobb, Howard
    Shah, Kushal
    Kannan, Pavitra
    Dersch, Christina M.
    Parrish, Damon
    Deschamps, Jeffrey R.
    Rothman, Richard B.
    Prisinzano, Thomas E.
    JOURNAL OF NATURAL PRODUCTS, 2006, 69 (06): : 914 - 918
  • [36] Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents
    D. Matthew Walentiny
    Robert E. Vann
    Jonathan A. Warner
    Lindsey S. King
    Herbert H. Seltzman
    Hernán A. Navarro
    Charles E. Twine
    Brian F. Thomas
    Anne F. Gilliam
    Brian P. Gilmour
    F. Ivy Carroll
    Jenny L. Wiley
    Psychopharmacology, 2010, 210 : 275 - 284
  • [37] Progress toward the total synthesis of salvinorin A: A potent, nonnitrogenous kappa-opioid receptor selective agonist.
    Vangapandu, S
    Phillip, A
    Stewart, JD
    Zjawiony, J
    Avery, MA
    McCurdy, CR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U351 - U351
  • [38] Syntheses of kappa-opioid receptor ligands: Salvinorin A analogs with modification at C-4 position.
    He, M
    Lee, DYW
    Liu-Chen, LY
    Ma, Z
    Wang, Y
    Chen, Y
    Carlezon, WA
    Beguin, C
    Cohen, BM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U117 - U118
  • [39] Ligand-receptor electrostatic interactions in molecular recognition of glutamate receptor.
    Kubo, M
    Shiomitsu, E
    Odai, K
    Sugimoto, T
    Suzuki, H
    Ito, E
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 160A - 160A
  • [40] Salvinorin A:: A novel and highly selective κ-opioid receptor agonist
    Feng, Y
    Roth, BL
    LIFE SCIENCES, 2004, 75 (22) : 2615 - 2619